Bioidentical hormone doses (for thyroid, testosterone, estrogen or cortisol) can be customized based on lab results and patient symptoms to support metabolism and energy levels
Currently, AD patients with positive tau pathology exhibit poor responsiveness to anti-A antibody treatments, which are ineffective in reducing tau levels [106]
With dedicated support from a team of passionate clinical pharmacists and proven patient adherence solutions, your patients can be confident to start, continue, and benefit from their GLP-1 therapy
Access to complimentary Virtual Workshops dedicated and tailored to members on the GLP-1 Program and led by experienced WeightWatchers Coaches
While more studies in psychiatric populations are needed, obesity and antipsychotic-induced obesity are more alike than different, and it is likely that other GLP-1 RAs will work in this population as well